Skip to main content

Table 3 Recalibration component of response shift effect assessed with the then-test method at each measurement time

From: Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients

 

Baseline HRQoL

Then-test 1 minus pre-test

Then-test 2 minus pre-test

HRQoL at three months

Then-test 3 minus pre-test

N

Mean (SD)

N

Mean (SD)

P

Effect size

N

Mean (SD)

P

Effect size

N

Mean (SD)

N

Mean (SD)

P

Effect size

QLQ-C30

                

Global Health Status

310

68.66 (20.52)

280

-0.80 (16.67)

0.600

-0.04

275

-4.21 (18.45)

<0.001

-0.21

300

60.02 (20.19)

266

0.91 (21.30)

0.48

0.05

Physical functioning

313

90.01 (15.50)

283

-0.50 (10.78)

0.987

-0.03

280

-1.59 (13.26)

0.053

-0.11

301

81.31 (16.76)

273

5.10 (14.52)

<0.001

0.31

Role functioning

309

89.28 (20.38)

281

-1.90 (18.70)

0.182

-0.09

282

-6.50 (23.72)

<0.001

-0.32

300

74.06 (30.16)

269

8.55 (28.99)

<0.001

0.30

Emotional functioning

308

64.86 (26.20)

279

5.36 (18.64)

<0.001

0.21

280

6.97 (21.48)

<0.001

0.27

300

72.80 (22.54)

270

-2.85 (24.55)

0.054

-0.11

Cognitive functioning

313

83.23 (20.76)

280

2.80 (14.97)

0.027

0.13

281

2.37 (18.27)

0.041

0.11

301

82.84 (21.11)

239

4.03 (20.80)

0.004

0.17

Social functioning

307

90.34 (18.88)

264

-0.51 (16.18)

0.644

-0.03

276

-5.01 (20.70)

<0.001

-0.27

298

81.37 (25.42)

266

6.02 (25.77)

<0.001

0.22

Fatigue

310

22.89 (22.92)

278

-1.48 (18.22)

0.039

-0.06

279

1.75 (20.92)

0.228

0.08

300

32.82 (24.08)

270

-11.03 (25.36)

<0.001

-0.43

Nausea and vomiting

312

3.53 (11.18)

270

-0.77 (8.34)

0.130

-0.07

282

1.77 (15.11)

0.092

0.16

299

3.44 (10.90)

269

-3.22 (19.95)

0.010

-0.18

Pain

316

12.45 (20.87)

285

0.53 (19.04)

0.897

0.02

283

3.24 (23.03)

0.032

0.15

304

25.08 (24.82)

274

-6.02 (23.98)

<0.001

-0.23

Dyspnea

310

11.72 (31.87)

280

-2.02 (15.19)

0.036

-0.09

279

-1.08 (15.58)

0.333

-0.05

301

12.86 (20.89)

269

-3.59 (24.08)

0.009

-0.15

Insomnia

307

38.11 (31.87)

277

-5.30 (27.14)

0.003

-0.17

274

-6.93 (30.94)

<0.001

-0.22

299

36.63 (30.27)

266

-5.64 (32.59)

0.002

-0.18

Appetite loss

312

11.75 (22.46)

280

-3.45 520.35

0.005

-0.15

280

-1.19 (23.75)

0.323

-0.05

299

10.20 (20.13)

267

-4.62 (25.02)

0.004

-0.18

Constipation

310

12.47 (22.80)

276

-1.09 (21.15)

0.520

-0.05

277

1.56 (24.93)

0.284

0.07

298

21.38 (30.87)

264

-4.29 (26.61)

0.006

-0.16

Diarrhea

309

8.63 (16.48)

278

-2.88 (12.66)

<0.001

-0.17

277

-2.89 (17.25)

0.010

-0.17

296

4.76 (12.30)

263

-0.63 (22.07)

0.483

-0.04

Financial difficulties

300

4.56 (14.60)

264

0.38 (12.83)

0.741

0.03

269

0.99 (16.51)

0.453

0.07

299

5.86 (15.93)

264

-2.15 (18.14)

0.048

-0.10

QLQ-BR23

                

Body image

295

90.04 (17.32)

262

-0.76 (11.95)

0.505

-0.05

257

-8.16 (16.96)

<0.001

0.48

302

70.76 (30.77)

269

7.78 (24.82)

<0.001

0.25

Sexual functioning

274

76.46 (24.01)

232

-0.50 (13.82)

0.207

-0.02

222

-1.21 (15.92)

0.206

-0.05

267

79.65 (22.06)

224

-4.69 (18.52)

0.002

-0.21

Sexual enjoyment

126

43.92 (28.79)

99

2.36 (11.91)

0.124

0.09

100

3.33 (22.97)

0.284

0.12

138

52.17 (29.31)

108

-1.54 (23.41)

0.548

-0.06

Future perspective

295

47.46 (30.86)

261

7.41 (30.60)

<0.001

0.24

259

6.95 (32.47)

<0.001

0.23

301

54.49 (32.76)

269

-0.12 (33.02)

0.968

-0.01

STSE

308

13.29 (15.30)

280

-1.71 (9.89)

0.008

-0.11

271

0.73 (13.84)

0.563

0.05

301

25.13 (20.20)

271

-4.76 (19.52)

<0.001

-0.24

Breast symptoms

273

11.25 (14.92)

243

-0.73 (14.39)

0.152

-0.05

239

2.15 (19.76)

0.379

0.14

302

24.73 (22.97)

273

-7.28 (20.70)

<0.001

-0.31

Arm symptoms

297

8.06 (14.42)

268

1.58 (18.49)

0.572

0.11

261

2.43 (16.53)

0.011

0.17

302

16.39 (18.54)

273

-2.71 (17.70)

0.010

-0.15

Hair loss

55

32.73 (36.57)

34

0.98 (17.38)

0.749

0.03

31

1.08 (25.07)

0.506

0.03

131

53.69 (39.78)

54

-8.03 (40.92)

0.173

-0.21

  1. P: Wilcoxon matched test P value.
  2. SD: standard deviation.
  3. Results in bold correspond to clinically and statistically significant results.